ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Participants With Crohn's Disease

ClinicalTrials.gov ID: NCT02782663

Public ClinicalTrials.gov record NCT02782663. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Open-Label Extension (OLE) Study to Observe the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Subjects With Crohn's Disease

Study identification

NCT ID
NCT02782663
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AbbVie
Industry
Enrollment
107 participants

Conditions and interventions

Interventions

  • ABT-494 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 17, 2016
Primary completion
Jul 17, 2025
Completion
Jul 17, 2025
Last update posted
Jul 30, 2025

2016 – 2025

United States locations

U.S. sites
27
U.S. states
18
U.S. cities
25
Facility City State ZIP Site status
UC San Diego Health System /ID# 150041 La Jolla California 92037
Univ California, San Francisco /ID# 149987 San Francisco California 94143-2204
Duplicate_University of Florida - Archer /ID# 150033 Gainesville Florida 32610
The Ctr for Gastro Disorders /ID# 150012 Hollywood Florida 33021
Nature Coast Clinical Research - Inverness /ID# 149975 Inverness Florida 34452-4717
Gastroenterology Associates of Central Georgia, LLC /ID# 149870 Macon Georgia 31201
GI Specialists of GA, PC /ID# 150015 Marietta Georgia 30060
Cotton O'Neil Clinical Research Center, Digestive Health /ID# 149900 Topeka Kansas 66606
Duplicate_University of Louisville /ID# 149884 Louisville Kentucky 40202
Investigative Clinical Research /ID# 149886 Annapolis Maryland 21401
Charm City Research Group /ID# 150040 Towson Maryland 21204
Clin Res Inst of Michigan, LLC /ID# 150008 Chesterfield Michigan 48047
Mayo Clinic - Rochester /ID# 149894 Rochester Minnesota 55905-0001
Kansas City Research Institute /ID# 149888 Kansas City Missouri 64131
Washington University-School of Medicine /ID# 149899 St Louis Missouri 63110
NYU Langone Long Island Clinical Research Associates /ID# 149976 Lake Success New York 11042
Weill Cornell Medicine/NYP /ID# 149895 New York New York 10021-4872
Univ NC Chapel Hill /ID# 149982 Chapel Hill North Carolina 27514-4220
University Of Cincinnati Medical Center /ID# 149977 Cincinnati Ohio 45219
Options Health Research, LLC /ID# 150010 Tulsa Oklahoma 74104
Texas Digestive Disease Consultants - Southlake /ID# 149869 Southlake Texas 76092
Texas Digestive Disease Consultants - Southlake /ID# 149989 Southlake Texas 76092
Aspen Clinical Research /ID# 150020 Orem Utah 84058
University of Virginia /ID# 149881 Charlottesville Virginia 22908
Virginia Mason Hospital & Medical Center /ID# 150042 Seattle Washington 98101
University of Washington /ID# 149988 Seattle Washington 98109
Wisconsin Center for Advanced Research /ID# 149863 Milwaukee Wisconsin 53215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02782663, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 30, 2025 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02782663 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →